AHLA's Top Ten Podcast Series

Jackie Papish, Partner, Barnes & Thornburg LLP, speaks with Emily Felder, Shareholder, Brownstein Hyatt Farber Schreck LLP, about how the One Big Beautiful Bill Act and reduced federal health care spending will continue to impact the health care industry in 2026. They discuss issues related to state directed payments/provider tax credits, work requirements, the Rural Health Transformation Program, Administration oversight of federal funds to the states, and implications as the midterm elections approach. From AHLA’s Hospitals and Health Systems Practice Group.

Zi Peng, Managing Director, StoneTurn, speaks with Alya Sulaiman, Chief Compliance and Privacy Officer & SVP of Regulatory Affairs, Datavant, about some of the primary issues around artificial intelligence (AI) in health care as organizations plan for 2026. They discuss the use of AI in prior authorization and utilization management, tensions between the federal government and the states over AI regulation, and actionable steps health care organizations should take to mitigate risk and ensure responsible AI deployment. Sponsored by StoneTurn.

Anna M. Lozoya, General Counsel, Physician Alliance Group PC, speaks with Miranda Franco, Senior Policy Advisor, Holland & Knight LLP, about the forces currently shaping public health policy and why 2026 marks a turning point. They discuss the advancement of the administration’s “Make America Healthy Again” agenda through the Center for Medicare and Medicaid Innovation, drug pricing, vaccine policy, and where health systems can devote resources based on current public health trends. From AHLA’s In-House Counsel Practice Group.

Okem Nwogu, Managing Director, StoneTurn, speaks with Megha Mathur, Associate, Barnes & Thornburg LLP, about recent trends in health care fraud and abuse enforcement and how health care organizations should respond. They discuss the shift in enforcement from volume to scale, compliance breakdowns that trigger scrutiny in areas that dominate enforcement like telehealth, the link between reimbursement and liability as it relates to risk-adjustment coding, and how compliance programs should adjust given the new data-driven enforcement approach. Sponsored by StoneTurn.

Jody Erdfarb, Partner, Wiggin and Dana LLP, speaks with Adam Greene, Partner, Davis Wright Tremaine LLP, about the health privacy and security developments that are taking center stage in 2026. They discuss the Part 2 and HIPAA notice of privacy practices changes (this podcast was recorded prior to the 2/16/26 deadline), the 2025 proposed amendments to the Security Rule, the 2021 proposed Privacy Rule changes, and state law developments. From AHLA’s Health Information and Technology Practice Group.

Mary R. Kohler, Founder & Principal, Kohler Health Law PC, speaks with Kristie C. Gurley, Partner, Covington & Burling LLP, about the targeted reform and broad shifts that U.S. drug pricing is currently undergoing. They discuss issues related to Inflation Reduction Act implementation, litigation, the Trump Administration’s approach to drug pricing, pharmacy benefit managers, and 340B. From AHLA’s Life Sciences Practice Group.

Zi Peng, Managing Director, StoneTurn, speaks with Leslie Overton, Partner, Axinn Veltrop & Harkrider LLP, about how health care organizations can navigate the current antitrust regulatory environment. They discuss how organizations are weighing the costs and benefits of mergers, the impact of the government’s current approach to settlements and remedies, antitrust traps related to information technology and labor, and DOJ’s new whistleblower program. Sponsored by StoneTurn.

Coming March 13, 2026.

Coming March 20, 2026.

Coming March 27, 2026.